SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-15-000429
Filing Date
2015-02-10
Accepted
2015-02-10 12:46:11
Documents
1
Period of Report
2015-02-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT almenoff-form4_020615.html 4  
1 OWNERSHIP DOCUMENT almenoff-form4_020615.xml 4 4586
  Complete submission text file 0001387131-15-000429.txt   6207
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 15592090